IFNA1 and systemic lupus erythematosus: It is the first study to demonstrate the inhibitory effects of 1, 25-D on SLE MDDC activation and transfer of the IFN signature in vitro and to show that MDDCs derived from SLE patients are responsive to changes in 1, 25-D concentration.